MedTrace Logo

Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women

NCT01069211 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 876

Last updated 2011-05-11

No results posted yet for this study

Summary

The purpose of this study is to assess clinical outcomes after Letrozole treatment according to the estrogen receptor expression in postmenopausal women with hormone receptor positive breast cancer.

Conditions

Sponsors & Collaborators

  • Korean Breast Cancer Study Group

    lead OTHER

Principal Investigators

  • Joon Jeong, MD · Department of Surgery, Gangnam Severance Hospital, South Korea

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01069211 on ClinicalTrials.gov